However, Klf4-deletion has also been shown to either directly underpin cancer development or progression, or disrupt processes relevant for cancer development or progression, in non-epithelial tissues, typically (but not exclusively) in the presence of a genetic (or other) compounding stressor. The gene discussed is KLF4; the disease is cancer.